Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-018104

AILERON THERAPEUTICS INC · ALRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 8:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 5, 2017C655,797—A655,797D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Preferred StockF2,F1—Jul 5, 2017C3,489,740D——Common Stock351,1860D
Series E-1 Preferred StockF2,F1—Jul 5, 2017C3,026,920D——Common Stock304,6110D

Explanation of responses